Sign In

Aishwarya Kundu

Director , Preclinical Research, PYC Therapeutics

Professional Background

Aishwarya Kundu is a performance-driven, independent, and proactive scientist renowned for her exceptional research expertise in Molecular Oncology and Stem Cell Biology. With an impressive career spanning over a decade in both academia and the biopharmaceutical industry, Aishwarya has demonstrated a strong commitment to advancing scientific knowledge and improving patient outcomes. Her multifaceted skill set encompasses various areas of cellular and molecular biology techniques, particularly focused on determining the anticancer therapeutic potential and mechanisms of action of small molecules, including natural phytochemicals and their synthetic derivatives.

Throughout her career, Aishwarya has effectively managed contract research organization (CRO)-based preclinical research projects aimed at indication expansion of drug products, alongside overseeing Phase I clinical studies in collaboration with clinical partners. Her ability to forge interdisciplinary collaborations with academic colleagues has led to an impressive achievement of three first-author publications within a short span of three years—an outstanding feat that reflects her dedication to innovative research and development.

Education and Achievements

Aishwarya's educational background is distinguished by her rigorous studies in Oncology at the prestigious University of California, Berkeley, where she earned her Doctor of Philosophy (PhD). She also studied Stem Cell Biology at the renowned Baylor College of Medicine and holds a Master of Science (MS) degree in Medical Biochemistry from Manipal Academy of Higher Education. Her foundational knowledge in sciences was developed during her Bachelor of Science (BS) studies in Chemistry, Microbiology, and Botany at Bangalore University.

Her training has equipped Aishwarya with a solid understanding of the intricacies of scientific research, allowing her to excel in complex problem-solving scenarios within the molecular oncology realm. In recognition of her excellence, she has received accolades including the Best Lecture Award and the Outstanding Graduate Student Instructor Award, showcasing her strong communication and presentation skills, essential for driving successful collaborations and sharing knowledge in her field.

Leadership and Management

In various roles, Aishwarya has demonstrated exemplary leadership capabilities by independently designing, leading, and mentoring a diverse research team comprised of seven undergraduates and visiting scholars. Her ability to provide guidance on three independent research projects illustrates her commitment to fostering the next generation of scientists and researchers. This hands-on experience in managing teams underscores her robust management skills, making her a valuable asset in any research or clinical setting.

As the current Director of Preclinical Research at PYC Therapeutics (ASX: PYC), Aishwarya continues to lead innovative research initiatives aimed at developing novel therapeutic strategies. Her past positions include Associate Director, Senior Scientist, Staff Scientist, Medical Science Liaison, and Global Medical Affairs Project Manager at Santen, where she has played a crucial role in pioneering various drug development projects. Additionally, her academic contributions continue through her prior research roles at esteemed institutions such as Washington University School of Medicine, the National Institute of Mental Health and Neuro Sciences, and Stempeutics Research Pvt. Ltd.

Notable Skills and Expertise

Aishwarya's diverse scientific expertise enables her to excel in a broad range of applications within oncology and stem cell research. Her proficiency in utilizing various cellular and molecular biology techniques is considerable, allowing her to assess the therapeutic potential of various drug substances effectively. Aishwarya's methodological prowess is complemented by her strong communication skills, which she has honed throughout her professional journey, making her an outstanding speaker and collaborator.

In summary, Aishwarya Kundu is an accomplished and talented scientist whose extensive background in Molecular Oncology and Stem Cell Biology positions her as a leader in the biopharmaceutical industry. Her commitment to research excellence, coupled with her strong management skills and collaborative spirit, continues to contribute significantly to the advancement of scientific knowledge and therapeutic development. As she progresses in her career, Aishwarya is sure to leave a lasting impact on the fields of oncology and drug discovery.

Related Questions

How did Aishwarya Kundu's background in Chemistry, Microbiology, and Botany contribute to her expertise in Molecular Oncology and Stem Cell Biology?
What innovative techniques has Aishwarya Kundu applied in her research to explore the therapeutic potential of phytochemicals in cancer treatment?
Can Aishwarya Kundu share insights on her experiences managing preclinical research projects and the collaborations she initiated with academic colleagues?
How does Aishwarya Kundu’s experience as a Medical Science Liaison enhance her capabilities in the field of clinical research and development?
What were some key milestones in Aishwarya Kundu's career that shaped her approach to leadership and mentoring within scientific research teams?
A
Add to my network

Location

Fremont, California, United States